Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Eric P. Krenning, James C. Yao et al.|New England Journal of Medicine|2017Cited by 3.2k
NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Combination With Anti-PD-1 Therapy: A Phase I StudyColette J. Shen, Tanguy Y. Seiwert, Jessica M. Frakes et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 4